Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

BUY
$43.74 - $62.76 $199,191 - $285,809
4,554 New
4,554 $284,000
Q4 2020

Feb 12, 2021

SELL
$42.19 - $51.5 $228,838 - $279,336
-5,424 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$35.33 - $51.04 $51,263 - $74,059
-1,451 Reduced 21.11%
5,424 $267,000
Q2 2020

Aug 13, 2020

SELL
$22.91 - $39.83 $147,929 - $257,182
-6,457 Reduced 48.43%
6,875 $237,000
Q4 2019

Feb 12, 2020

BUY
$19.57 - $28.96 $260,907 - $386,094
13,332 New
13,332 $362,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.